Bayer is stepping up the legal defense of its flagship weed killer, after a verdict in a recent case alleging the chemical causes cancer sent shares tumbling and raised the prospect of costly payouts.
from WSJ.com: US Business https://ift.tt/2NS4EkO
via IFTTT
No comments:
Post a Comment